GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-1,049 Cr | ₹-1,805 Cr | ₹-1,655 Cr | ₹-1,506 Cr | ₹-1,439 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-1,049 Cr |
Mar2023 | ₹-1,805 Cr |
Mar2022 | ₹-1,655 Cr |
Mar2021 | ₹-1,506 Cr |
Mar2020 | ₹-1,439 Cr |
How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,049 Cr | Negative | |
Mar2023 | ₹-1,805 Cr | Negative | |
Mar2022 | ₹-1,655 Cr | Negative | |
Mar2021 | ₹-1,506 Cr | Negative | |
Mar2020 | ₹-1,439 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹61,621.2 Cr | -2% | 33.4% | 57.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -2% |
33.4% |
57.6% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses